1 侯娟娟,虎淑妍,刘婷婷,等. 血清肿瘤标志物在卵巢癌早期诊断中的临床价值[J]. 中国免疫学杂志,2014,30(8):1101-1104. 2 张文琪,郝权. 术前外周血NLR对上皮性卵巢癌患者预后的影响[J]. 中国肿瘤临床,2014,41(10):634-638. 3 贾素娟,王治洁,张美琴,等. 血清CA125、HE4和影像学检查在上皮性卵巢癌术后复发诊断中的应用价值[J]. 中国癌症杂志,2015,25(6):452-456. 4 韩建,倪锦红,卢美松.围术期护理对老年卵巢癌患者的效果观察[J].中国肿瘤临床与康复,2017,24(03):329-332. 5 Hamilton M P,Rajapakshe K,Hartig S M,et al. Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif[J]. Nature Communications,2015,4(4):2730. 6 范淑英,王健,刘芸,等. 紫杉醇联合卡铂周疗和三周疗法治疗卵巢癌的Meta分析[J]. 解放军医学杂志,2016,41(7):589-597. 7 哈丽亚•哈力木别克,薄小莉, 祖拉亚提•库尔班,等. 血清CA125对卵巢上皮性癌的诊断及临床分期的价值[J]. 新疆医科大学学报,2012,35(1):61-64. 8 Bertoli G,Cava C,Castiglioni I. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.[J]. Theranostics,2015,5(10):1122-43. 9 Koturbash I, Tolleson W H,Guo L,et al. microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment[J]. Biomarkers in Medicine, 2015,9(11):1153. 10 Chan J K, Blansit K, Kiet T, et al. The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer.[J]. Gynecologic Oncology, 2014, 132(3):739-744. 11 Braun J,Hoangvu C,Dralle H,et al. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas.[J]. Oncogene,2010,29(29):4237-4244. 12 Tang H,Kong Y, Guo J, et al. Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22.[J]. Cancer Letters, 2013,340(1):72-81. 13 Sun J,Chen Z,Tan X,et al. MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma[J]. Medical Oncology,2013,30(1):1-9. 14 Yu J,Li A,Hong S M,et al. MicroRNA alterations of pancreatic intraepithelial neoplasias.[J]. Clinical Cancer Research An Official Journal of the American Association for Cancer Research,2012,18(4):981. 15 Meng W,Ye Z,Cui R,et al. MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma.[J]. Clinical Cancer Research An Official Journal of the American Association for Cancer Research, 2013, 19(19):5423-5433. |